RxDoctor Payments Data

Raj Sureja, MD

Interventional Pain Medicine · Newport News, VANPI 1912967746

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (55.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 79.7% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2020 at $7,155 and has fallen 73.7% since, to $1,881 in 2025. Among interventional pain medicine clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$22,602in general payments, 2019–2025

Across 120 payments — averaging $188.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$18K
  • Medtronic$2K
  • MML US, Inc.$1K
  • Painteq LLC$404
  • Saluda Medical Americas, Inc.$172
  • Nevro Corp.$150
  • plus $322 from 5 others

What the payments were for

  • Consulting fees$1,6007%
  • Speaking & faculty fees$12,53855%
  • Travel & lodging$2,0159%
  • Food & beverage$6,44929%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,602 in reported general payments places this provider in the 90th percentile of 52 interventional pain medicine providers in Virginia.

See all interventional pain medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$755,719
Medicare patients
655
Services billed
37,930

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib67$3,738
Lidocaine35$2,532
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen108$2,233
Gabapentin132$1,678
Pregabalin37$1,120
Fentanyl14$929
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen54$807
Diclofenac Sodium18$748
Tizanidine Hcl23$511
Hydromorphone Hcl18$430
Tramadol Hcl57$428
Duloxetine Hcl24$366
Methocarbamol31$322
Cyclobenzaprine Hcl24$254
Acetaminophen-CodeineAcetaminophen With Codeine18$207

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Newport News

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →